PAUL SCHIMMEL Insider Trading
Get free email notifications about insider trading for PAUL SCHIMMEL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PAUL SCHIMMEL. PAUL SCHIMMEL is a Director in ALKERMES INC ($ALKS) and a Director in ALNYLAM PHARMACEUTICALS, INC. ($ALNY) and a Director in aTYR PHARMA INC ($LIFE) and a Director in Tocagen Inc ($TOCA).
Address: 88 SIDNEY STREET CAMBRIDGE 02139 MA
Companies in which PAUL SCHIMMEL is an Insider
ALKERMES INC
Trading Symbol: ALKSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PAUL SCHIMMEL: Director
Holdings: 355,600 shares
Current Value: $19,476,212
Latest Transaction: Sep 22 2006
$ALKS Market Capitalization: $8.27B
$ALKS Previous Close: $54.77
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ALNYLAM PHARMACEUTICALS, INC.
Trading Symbol: ALNYIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PAUL SCHIMMEL: Director
Holdings: 10,000 shares
Current Value: $404,600
Latest Transaction: Jul 02 2019
$ALNY Market Capitalization: $3.49B
$ALNY Previous Close: $40.46
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
aTYR PHARMA INC
Trading Symbol: LIFEIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of PAUL SCHIMMEL: Director
Holdings: 429,143 shares
Current Value: $1,459,086
Latest Transaction: Apr 29 2021
$LIFE Market Capitalization: $78.27M
$LIFE Previous Close: $3.40
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Forte Biosciences, Inc.
Trading Symbol: TOCAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PAUL SCHIMMEL: Director
Holdings: 23,464 shares
Latest Transaction: Oct 04 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of PAUL SCHIMMEL
Sentiment: All, ALKS, ALNY, LIFE, TOCA
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 29 2021 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Option Exercise | A | 4.21 | 1,428 | 6,012 | 1,428 | |
May 22 2020 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Sell | S | 3.64 | 8,447 | 30,739 | 429,143 | 437.6 K to 429.1 K (-1.93 %) |
May 08 2020 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Option Exercise | A | 3.65 | 1,428 | 5,212 | 1,428 | |
Feb 11 2020 | LIFE | aTYR PHARMA INC | SCHIMMEL PAUL | Director | Buy | P | 4.25 | 254,000 | 1,079,500 | 437,590 | 183.6 K to 437.6 K (+138.35 %) |
Oct 04 2019 | TOCA | Tocagen Inc | SCHIMMEL PAUL | Director | Option Exercise | A | 0.64 | 7,500 | 4,793 | 7,500 | |
Oct 04 2019 | TOCA | Tocagen Inc | SCHIMMEL PAUL | Director | Option Exercise | A | 0.64 | 7,500 | 4,793 | 7,500 | |
Jul 02 2019 | ALNY | ALNYLAM PHARMACEUT ... | SCHIMMEL PAUL | Director | Option Exercise | A | 72.01 | 9,000 | 648,090 | 9,000 |